Related content

Nationwide, multicenter survey on the efficacy and safety of piperacillin for adult community-acquired pneumonia in Japan

By Yamamoto Yoshihiro  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 4, 2012-08 ,pp. : 544-551

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study*

By Réa-Neto Álvaro   Niederman Michael   Margareth Lobo Suzana   Schroeder Eric   Lee Michael   Kaniga Koné   Ketter Nzeera   Prokocimer Philippe   Friedland Ian  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2113-2126

Informa Healthcare

Access to resources Recommend Favorite

Retrospective investigation of the clinical effects of tazobactam/piperacillin and sulbactam/ampicillin on aspiration pneumonia caused by Klebsiella pneumoniae

By Tsukada Hiroki  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 5, 2012-10 ,pp. : 715-721

Springer Publishing Company

Access to resources Recommend Favorite

Time to clinical stability among children hospitalized with pneumonia

By  

JOURNAL OF HOSPITAL MEDICINE, Vol. 10, Iss. 6, 2015-06 ,pp. : 380-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae : nested cohort within a multicenter clinical trial

By Fujita Jiro  

Journal of Infection and Chemotherapy, Vol. 19, Iss. 3, 2013-06 ,pp. : 472-479

Springer Publishing Company

Access to resources Recommend Favorite